Supply of medicines – Active substance rozanolizumab – ATC L04AL02
Dodávky léků – Léčivá látka rozanolixizumab – ATC L04AL02
Czechia · Praha · how to bid here →
Your path to submission
- Deadline: 27 October at 09:15 — 23 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: CES.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (233 awards, most recently September 2026) — the next award is due around October 2026 by that rhythm. The last award went to PHOENIX lékárenský velkoobchod, s.r.o..n = 233
- 38% of this buyer's awards went to companies that had already won here before (486 awards since 2020, spread over 100 companies). That is well below the sector norm (69%) — this buyer switches suppliers more often than others.n = 486 awards since 2020
- The median procedure drew just one bid (395 procedures with a bid count); 62% ended with a single bidder. Sector: median 2 bids.n = 395
- The award came in at a median 97% of the estimated value (105 awards with both estimate and value) — pricing at the estimate is usually about right here. Sector: 93%.n = 105
- 7% of awards went to companies from abroad (486 awards with a known winner country). Sector average: 10%.n = 486
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Czechia · Medical equipment & pharma, 101 contracts went to foreign companies over the last 3 years (of 16,917 recorded awards) — mostly from Germany, Poland, Austria.
Submission language: CES.
Typical field: median 1 (from 186 awards).
What the buyer is looking for
The subject of the contract is the continuous supply of a medicinal product containing the active substance rozanolixizumab – ATC L04AL02. pharmaceutical form 140MG/ML INJ SOL 1X2ML, unit of measurement 1X2ML, quantity 600 pharmaceutical form 140MG/ML INJ SOL 1X3ML, unit of measurement 1X3ML, quantity 100
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in Czech.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| PHOENIX lékárenský velkoobchod, s.r.o. | 36 | 2022–2026 |
| Alliance Healthcare s.r.o. | 32 | 2022–2026 |
| PROMEDICA PRAHA GROUP, a.s. | 17 | 2022–2026 |
| ROCHE s.r.o. | 13 | 2022–2026 |
| SKY & FACILITY s.r.o. | 12 | 2025–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.